123
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3703 |
ABT-639
ABT 639 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
ABT-639 是一种有效的选择性 T 型钙通道阻滞剂。 | |||
T26526 |
Abt-288
ABT 288,ABT288 |
Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
ABT-288 是一种具有选择性和高效性的 H3 拮抗剂,可用于治疗轻度至中度阿尔茨海默氏痴呆。 | |||
T29522 |
ABT 102
ABT102,CHEMBL398338,ABT-102 |
TRP/TRPV Channel | Membrane transporter/Ion channel |
ABT 102 (CHEMBL398338) 是瞬时受体电位香草素 1 (TRPV1) 受体的选择性拮抗剂。 | |||
T24997 |
ABT-510 acetate
ABT 510 acetate |
Apoptosis | Apoptosis |
ABT-510 acetate 是一种内源性抗血管生成的 TSP 肽抑制剂,是一种凝血酶原类似物,具有抗炎抗癌和抗血管生成活性,能诱导肿瘤细胞凋亡并抑制上皮性卵巢癌正位、同种异体模型中的卵巢肿瘤生长。ABT-510 acetate 可减少小鼠炎症性肠病模型的血管生成和炎症反应,可用于癌症 (尤其是上皮性卵巢癌) 以及炎症性肠病 (IBD) 的研究。 | |||
T14087 |
ABT-239
|
TRP/TRPV Channel | Membrane transporter/Ion channel |
ABT-239是一种新型、高效、非咪唑类H3R 拮抗剂,也是一种TRPV1拮抗剂。 | |||
T26531 |
ABT-963
ABT963 |
||
ABT-963 is a cyclooxygenase 2 (COX-2) inhibitor potentially for the treatment of osteoarthritis and pain. ABT-963 has excellent selectivity in human whole blood, high oral anti-inflammatory potency in vivo, and gastric safety in the animal studies. | |||
T4668 |
ABT-702 dihydrochloride
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
ABT-702 dihydrochloride 是腺苷激酶抑制剂,IC50为1.7 nM。 | |||
T7834 |
ABT-724
2 - [(4-吡啶-2-基哌嗪-1-基)甲基]-1H-苯并咪唑 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
ABT-724 是高度选择性的多巴胺D4受体激动剂,对人多巴胺D4受体的EC50=12.4 nM。它是大鼠D4(EC50为 14.3 nM) 和雪貂D4受体 (EC50为 23.2 nM) 的有效部分激动剂,对多巴胺 D1,D2,D3或 D5受体没有影响。它可用于勃起功能障碍的研究,并具有较少的副作用。 | |||
T22019 |
ABT 724 trihydrochloride
|
Dopamine Receptor | GPCR/G Protein; Neuroscience |
ABT 724 trihydrochloride 是一种有效的选择性 D4 受体激动剂(EC50 = 12.4 nM,14.3 nM 和 23.2 nM,分别对人、大鼠和雪貂)。 ABT-724 trihydrochloride 可用于勃起功能障碍研究。 | |||
T1758 |
ABT-751
E7010 |
Microtubule Associated; Autophagy | Autophagy; Cytoskeletal Signaling |
ABT-751 (E7010) 是一种新型的生物相容性的微管蛋白结合剂,用于治疗肺癌、非小细胞肺癌和非小细胞肺癌。它是磺胺类抗有丝分裂抑制剂,对神经母细胞瘤细胞株和非神经母细胞瘤细胞株的IC50分别为1.5 和 3.4 μM。 | |||
T12653 |
(Rac)-ABT-202 dihydrochloride
|
AChR | Neuroscience |
(Rac)-ABT-202 dihydrochloride 是 ABT-202 的外消旋体。ABT-202 是烟碱乙酰胆碱受体激动剂,可用作镇痛剂。 | |||
T2099 |
ABT-737
|
Mitophagy; BCL; Autophagy | Apoptosis; Autophagy |
ABT737 是 BH3 模拟物,是Bcl-2、Bcl-xL 和Bcl-w 抑制剂,EC50分别为 30.3 nM、78.7 nM 和 197.8 nM。它诱导自噬,有研究急性髓系白血病的潜力。它还诱导 BCL-2/BAX 复合物的破坏和 BAK 依赖性。 | |||
T26524 |
ABT-080
VML530,VML-530,VML 530,ABT080 |
Leukotriene Receptor | GPCR/G Protein |
ABT-080 (VML 530)是白三烯合成的抑制剂,有用于治疗哮喘的潜力。 | |||
T29522L |
(S)-ABT 102
|
TRP/TRPV Channel | Membrane transporter/Ion channel |
N-[(1S)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea 是一种有效的TRPV1拮抗剂,其IC50为123 nM,可阻断capsaicin 对TRPV1的激活。 | |||
T5126 |
Glecaprevir
ABT-493 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Glecaprevir (ABT-493) 是一种新型的 HCV NS3/4A 蛋白酶抑制剂,其 IC50值在 3.5 和 11.3 nM 之间。它也是 SARS-CoV 3CLpro 的抑制剂,IC50为 4.09 μM。 | |||
TQ0002 |
A-317491
ABT 202 |
P2X Receptor | Membrane transporter/Ion channel; Neuroscience |
A-317491 (ABT 202) 是选择性和非核苷酸的 P2X3和 P2X2/3受体的拮抗剂,通过阻断 P2X3和 P2X2/3受体介导的钙通量减轻炎性和神经性疼痛。它对其他 P2 受体和神经递质受体,离子通道以及酶具有高度选择性,IC50大于10 μM。 | |||
T29530 |
ABT-515
ABT 515,UNII-186W5U73P9 |
||
ABT-515 is a bio-active chemical. Detailed information has not been published. | |||
T11638 |
Ilorasertib hydrochloride
ABT-348 hydrochloride |
Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic |
Ilorasertib hydrochloride (ABT-348 hydrochloride) is an ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A (IC50s: 1 nM, 7 nM, 120 nM). It also suppresses RET tyrosine kinase, PDGFRβ, and Flt1 (IC50s: 7 nM, 3 nM, and 32 nM). | |||
T29531 |
ABT-719 HCl
A-816719.1,A 816719.1,ABT-719,ABT719,ABT 719,ABT-719 hydrochloride |
||
ABT-719 is a 2-pyridinone antimicrobial agent that is more effective against Enterococcus faecalis strains than ciprofloxacin and vancomycin, which showed resistance to ciprofloxacin and vancomycin covering a range of MIC. | |||
T77437 |
Telisotuzumab
ABT-700,Mab-224G11 |
c-Met/HGFR | Tyrosine Kinase/Adaptors |
Telisotuzumab(ABT-700) 是一种人源化重组抗体,靶向治疗性肝细胞生长因子受体(MET)的抗体,对 c-Met 具有很高的亲和力 。Telisotuzumab 对 c-Met 信号传导具有抑制作用且具有抗肿瘤活性。 | |||
TQ0059 |
Ilorasertib
ABT-348 |
VEGFR; FLT; c-RET; PDGFR; Aurora Kinase | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors |
Ilorasertib (ABT-348) 是一种 ATP 竞争性多靶点激酶抑制剂,可抑制 Aurora A、Aurora B 和Aurora C,IC50值为120 nM、7 nM 和1 nM。它还抑制 RET 酪氨酸激酶、PDGFRβ 和 Flt1,IC50为7 nM、3 nM 和 32 nM。 | |||
T29526 |
ABT-202
ABT 202 |
||
ABT-202 is a drug developed by Abbott that acts as an agonist for the nerve's nicotinic acetylcholine receptor and has been studied as a painkiller. | |||
T5127 |
ABT530
ABT 530,ABT-530,哌仑他韦,Pibrentasvir |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
ABT530 (Pibrentasvir) 是一种 HCV NS5A 抑制剂,针对含有 NS5A 基因型 1-6 的 HCV 复制子,EC50 范围为 1.4-5.0 pM。 | |||
T2101 |
Navitoclax
ABT-263 |
BCL | Apoptosis |
Navitoclax (ABT-263) 是一种 Bcl-2 抑制剂,可与 Bcl-xL、Bcl-2、Bcl-w 等蛋白结合 (Ki<1 nM),具有有效性和口服活性。Navitoclax 具有抗肿瘤活性,可以诱导细胞凋亡。 | |||
T29524 |
ABT 491 Hydrochloride
ABT491,ABT-491,ABT 491 |
||
ABT-491 hydrochloride is an active platelet activator receptor (PAF-R) antagonist with good selectivity and oral administration. | |||
T10213 |
A-437203
ABT-925,A37203,Lu201640 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
A-437203 (Lu201640) 是一种基于1H-pyrimidin-2-one scaffold 的、具有选择性的、新型强效的d3受体拮抗剂,对 D2, D3, 和 D4 受体,的Ki 值分别为 71, 1.6 和 6220 nM。 | |||
T7158 |
Ombitasvir
奥比他韦,ABT-267 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Ombitasvir (ABT-267) 是丙型肝炎病毒非结构蛋白 5A 的口服生物可利用的强效抑制剂。对 HCV 基因型 1 至 5 的 EC50 为 0.82 至 19.3 pM,对基因型 6a 的 EC50 为 366 pM。 | |||
T7503 |
Upadacitinib
乌帕替尼,ABT-494 |
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
Upadacitinib (ABT-494) 是高效选择性的,具有口服活性的 JAK1抑制剂,IC50为43 nM,可用于多种自身免疫性疾病的研究。它对 JAK1 的选择性约为 JAK2 的 74 倍。 | |||
T12186 |
Navitoclax-piperazine
ABT-263-piperazine |
BCL; Ligands for Target Protein for PROTAC | Apoptosis; PROTAC |
Navitoclax-piperazine (ABT-263-piperazine) 是一种特大型 B 细胞淋巴瘤(BCL-XL)抑制剂。它和 E3 泛素连接酶的 VHL 配体可用来合成 PROTAC DT2216。 | |||
T76863 |
Elezanumab
AE12-1Y-QL,ABT-555 |
TGF-beta/Smad | Stem Cells |
Elezanumab(ABT-555) 是一种有效的人抗 RGMa 单克隆抗体。Elezanumab 通过 SMAD1/5/8 通路发挥对 RGMa 介导的 BMP 信号传导的抑制作用,IC50 约为 97 pM。在神经元损伤和脱髓鞘模型中,Elezanumab 促进神经再生、神经保护和神经恢复。Elezanumab 促进皮质脊髓轴突生长为脊髓灰质,并增强腹角的血清素能神经支配,形成颈部病变尾部的突触连接。 | |||
T29523 |
ABT 29666
ABT-29666,ABT29666 |
||
ABT 29666 is a therapeutic agent. | |||
T29528 |
ABT-279
ABT279,ABT 279 |
||
ABT-279 is a bio-active chemical. | |||
T29534 |
ABT-925 fumarate dihydrate
ABT 925,LU201640,ABT925,ABT-925,BSF201640,DAT201 |
||
ABT-925 is a selective dopamine D3 receptor (DRD3) antagonist with an in vitro affinity approximately 100 times higher for dopamine D3 receptors than for D2 receptors. | |||
T1623 |
Lopinavir
ABT-378,洛匹那韦 |
SARS-CoV; HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Lopinavir (ABT-378) 是一种选择性肽模拟 HIV-1 蛋白酶的高效抑制剂。它通过阻止 HIV-1 的成熟而起作用,从而阻断其感染性。它也是 SARS-CoV 3CLpro 的抑制剂。 | |||
T3489 |
Dasabuvir
ABT-333,达塞布韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dasabuvir (ABT-333) 是丙型肝炎病毒非结构蛋白 5B 的非核苷抑制剂,是一种 RNA 依赖性 RNA 聚合酶,具有抗 HCV 的潜在活性。 | |||
T69599 |
ABT-510
|
||
ABT-510 is synthetic peptide that mimics the anti-angiogenic activity of the endogenous protein thrombospondin-1 (TSP-1). ABT-510 inhibits the actions of several pro-angiogenic growth factors important to tumor neovascularization; these pro-angiogenic growth factors include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF)), hepatocyte growth factor (HGF), and interleukin 8 (IL-8). | |||
T41209 |
DPNB-ABT 594
|
||
DPNB-ABT 594 is a nitrobenzyl-caged ABT 594, a selective α4β2 nAChR agonist. One-photon uncaging evokes large inward currents and Ca2+transients on cell bodies and dendrites of medial habenular neurons in mouse brain slices. Two-photon uncaging induces fast nAChR-mediated currents. Photolyzed with high quantum yield of 0.20. Effective photolysis occurs using one- or two-photon excitation; one-photon uncaging requires illumination at 410 nm for 1.5-3 ms; two-photon uncaging requires illumination ... | |||
T29533 |
ABT-866
ABT 866,A 286666 |
||
ABT-866 is a novel alpha-adrenoceptor agent with mixed pharmacological properties. | |||
T29527 |
ABT-255
ABT 255,ABT255,UNII-YA04O24J4T |
||
ABT-255 is a novel 2-pyridone antimicrobial agent for the treatment of tuberculosis. Both drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis showed efficacy in vitro and in vivo. | |||
T38346 | ABT 702 hydrochloride | ||
Potent non-nucleoside adenosine kinase inhibitor (IC50 = 1.7 nM), selective over other sites of adenosine interaction (A1, A2A and A3 receptors, adenosine transporter and adenosine deaminase). Displays oral activity in animal models of pain and inflammation. | |||
T3226 |
Paritaprevir free base
ABT-450,Veruprevir,帕利瑞韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Paritaprevir free base (ABT-450) 是一种口服生物可利用的合成酰基磺酰胺抑制剂,可抑制丙型肝炎病毒 (HCV) 蛋白酶复合物,由非结构蛋白 3 和 4A (NS3/NS4A) 组成,对 HCV 基因型 1 具有潜在活性。 给药后,paritaprevir 可逆地结合 HCV NS3/NS4A 蛋白酶的活性中心和结合位点,并阻止 NS3/NS4A 蛋白酶介导的多蛋白成熟。这会破坏病毒蛋白的加工和病毒复制复合物的形成,从而抑制病毒在 HCV 基因型 1 感染的宿主细胞中的复制。 NS3 是一种丝氨酸蛋白酶,对于 HCV 多蛋白内多个位点的蛋白水解切割至关重要,并且在 HCV 核糖核酸 (RNA) 复制过程中起关键作用。 NS4A 是 NS3 的激活因子。 HCV 是属于黄病毒科的一种小的、有包膜的单链 RNA 病毒,感染与肝细胞癌 (HCC) 的发展有关。 | |||
T26525 |
ABT-281
ABT 281,A-86281,A 86281,ABT281,A86281 |
||
ABT-281 is an ascomycin analog and a macrolactam T cell inhibitors with potent topical activity and reduced systemic exposure. | |||
T2591 |
Veliparib
ABT-888,NSC 737664,维利帕尼 |
PARP; Autophagy | Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair |
Veliparib (ABT-888) 是一种可口服的 PARP 抑制剂,抑制PARP1和PARP2的Ki 分别为 5.2 和 2.9 nM。它增强细胞凋亡和自噬。 | |||
T2119 |
Venetoclax
GDC-0199,ABT 199,维奈妥拉,ABT-199,ABT199 |
BCL; Autophagy | Apoptosis; Autophagy |
Venetoclax (ABT-199) 是一种 Bcl-2 抑制剂 (Ki<0.01 nM),具有高效性、选择性和口服活性。Venetoclax 与 Bcl-xL 和 Bcl-W 的亲和力降低了 3 个数量级(Kis=48/245 nM)。Venetoclax 可以诱导自噬和凋亡。 | |||
T29529 |
ABT-491 free base
ABT 491,ABT-491,ABT491 |
||
ABT-491 free base is a bio-active chemical. Detailed information has not been published. | |||
T0212 |
Seratrodast
塞曲司特,AA 2414,ABT-001 |
COX; Prostaglandin Receptor; PPAR | DNA Damage/DNA Repair; GPCR/G Protein; Immunology/Inflammation; Metabolism; Neuroscience |
Seratrodast (ABT-001) 是一种血栓素 A2 受体 (TP) 拮抗剂,用于治疗哮喘。 | |||
T11286 |
Fiduxosin
A 185980.1,ABT 980 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Fiduxosin 是一种具有选择性和有效性的 α1-adrenoceptor 拮抗剂,对 α1a-adrenoceptor,α1b-adrenoceptor 和 α1d-adrenoceptor 有抑制作用,Ki 值分别为 0.160 nM,24.9 nM 和 0.920 nM。Fiduxosin 可用于治疗良性前列腺增生。 | |||
T3941 |
Choline Fenofibrate
Trilipix,ABT-335,非诺贝特胆碱 |
P450; COX; PPAR | DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism; Neuroscience |
Choline Fenofibrate (Trilipix) 是 Fenofibric acid 的胆碱盐,在胃肠道中释放游离的 Fenofibric acid。Fenofibric acid 是一种合成的苯氧基异丁酸衍生物和具有抗高血脂活性的前药。 | |||
T26529 |
ABT-418
ABT 418,ABT418,A 81418,A81418,A-81418 |
||
ABT-418, a nicotinic acetylcholine receptor (nAchR) agonist, is used potentially for the treatment of attention deficit disorder. | |||
T26527 |
ABT-299
|
||
ABT-299 is a prodrug of A-85783. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13430 |
ABTL-0812
α-羟基油酸,α-Hydroxylinoleic acid |
Others | Others |
ABTL-0812 induces endoplasmic reticulum (ER) stress-mediated autophagy, and with anti-cancer activity. |